medigraphic.com
Colegio de Medicina Interna de México.

2022, Number 6

<< Back Next >>

Med Int Mex 2022; 38 (6)

Chronic mucocutaneous candidiasis in a patient with autoimmune polyendrocrine syndrome type 1

García-Mendoza P, Aquino-León L, Vega-Sánchez DC, Ortega-Springall F, Arenas-Guzmán R

Language: Spanish
References: 11
Page: 1274-1278
PDF size: 212.59 Kb.


ABSTRACT

Background: Chronic mucocutaneous candidiasis is a primary immunodeficiency characterized by chronic and recurrent non-invasive infections caused by Candida in skin, nails and mucous membranes, as well as associated autoimmune manifestations and endocrinopathies.
Clinical case: A 42-year-old male patient, with chronic mucocutaneous candidiasis with multiple recurrences, so he has been treated with different azolic derivates.
Conclusions: Chronic mucocutaneous candidiasis is part of the primary immunodeficiencies and has an important clinical diversity, it can cause complications due to chronic Candida infection, such as: keratoconjunctivitis, esophageal stenosis, squamous cell carcinoma of the mouth and esophagus.


REFERENCES

  1. Hani U, Shivakumar HG, Vaghela R, Osmani R, et al. Candidiasis:A fungal infection-Current challenges and progress inprevention and treatment. Infect Disord Drug Targets 2015;15 (1): 42-52. doi: 10.2174/1871526515666150320162036.

  2. Maya-Rico AM, Cardona-Castro N. Candidiasis mucocutáneacrónica: una mirada al entendimiento genético.Iatreia 2018; 31 (4): 393-399. DOI 10.17533/udea.iatreia.v31n4a06.

  3. Villanueva-Reyes, J, Arenas, R. Candidiasis mucocutánea.Una revisión. Rev Mex Micología 2007; 25: 91-104.

  4. Arenas R. Dermatología: Atlas, diagnóstico y tratamiento,7ª ed. México: McGraw-Hill 2019: 525-532.

  5. Chaim M Roifman. Chronic mucocutaneous candidiasis.Post TW, ed. UpToDate. Waltham, MA, 2020.

  6. Okada S, Puel A, Casanova JL, Kobayashi M. Chronic mucocutaneouscandidiasis disease associated with inbornerrors of IL-17 immunity. Clin Transl Immunol 2016:5: e114. doi: 10.1038/cti.2016.71.

  7. Humbert L, Cornu M, Proust-Lemoine E, Bayry J, et al.Chronic mucocutaneous candidiasis in autoimmune polyendocrinesyndrome type 1. Front Immunol 2018; 19: 9.doi: 10.3389/fimmu.2018.02570.

  8. Bello MO, Garla VV. Polyglandular autoimmune syndrometype I. [Updated 2019 Jun 4]. In: StatPearls [Internet]. TreasureIsland (FL): StatPearls Publishing; 2020 Jan-. Disponibleen: https://www.ncbi.nlm.nih.gov/books/NBK537211/.

  9. Kayiran M, Erdemir AV, Dagdelen D, Cebeci F, et al. A rarefungal infection of infants: a diffuse case of mucocutaneouscandidiasis. Int J Dermatol 2020; 59 (2): 259-262. doi:

  10. 10.1111/ijd.14644.10. Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 2006;91: 2843-50. doi: 10.1210/jc.2005-2611.

  11. Husebye ES, Perheentupa J, Rautemaa R, Kämpe O.Clinical manifestations and management of patientswith autoimmune polyendocrine syndrome type I. Int JIntern Med 2009; 265 (5): 514-29. doi: 10.1111/j.1365-2796.2009.02090.x.




2020     |     www.medigraphic.com